Medical versus surgical abortion

被引:14
作者
Cabezas, E [1 ]
机构
[1] Eusebio Hernandez Hosp, Dept Obstet & Gynecol, J Grupo Nacl Ginecobstet, Havana, Cuba
关键词
mifepristone; misoprostol; medical abortion; safety;
D O I
10.1016/S0020-7292(98)00196-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the safety, efficacy, and acceptability of an oral drug regimen of medical abortion compared with surgical abortion. Materials and methods. 500 women with amenorrhea < 56 days chose either surgical abortion or 600 mg of mifepristone (RU-486) followed by 400 mu g of misoprostol after 48 h. Results: Medical regimen had more side effects than surgical abortion, including bleeding, cramping, nausea and vomiting. Only fever was more frequent in the surgical method. The failure rates for medical abortion exceeded those for surgical abortion, 16.0% vs. 4.0%. The adolescents' failure rate in the medical regimen group was only 1.7%. Several failures on medical abortion were not true drug failures, but surgical interventions not medically necessary (misdiagnosis). Women were satisfied with either method, but more preferred medical abortion. Conclusion: Medical methods are safe, effective, simpler and potentially allow greater privacy than surgical abortion methods. Therefore, medical methods could be the method of choice for abortion, particularly for adolescents. (C) 1999 International Federation of Gynecology and Obstetrics.
引用
收藏
页码:S141 / S146
页数:6
相关论文
共 16 条
  • [1] RU-486 AS AN ANTIPROGESTERONE STEROID - FROM RECEPTOR TO CONTRAGESTION AND BEYOND
    BAULIEU, EE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (13): : 1808 - 1814
  • [2] Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion
    Bugalho, A
    Faundes, A
    Jamisse, L
    Usfa, M
    Maria, E
    Bique, C
    [J]. CONTRACEPTION, 1996, 53 (04) : 243 - 246
  • [3] Methotrexate and misoprostol for early abortion: A multicenter trial .1. Safety and efficacy
    Creinin, MD
    Vittinghoff, E
    Keder, L
    Darney, PD
    Tiller, G
    [J]. CONTRACEPTION, 1996, 53 (06) : 321 - 327
  • [4] David H.P., 1981, Abortion and Sterilization: Medical and Social Aspects
  • [5] FATHALLA MF, 1992, REPROD HLTH KEY BRIG, P3
  • [6] Illegal abortion: Consequences for women's health and the health care system
    Faundes, A
    Hardy, E
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1997, 58 (01) : 77 - 83
  • [7] GREENSLADE FC, 1993, MANUAL VACUUM ASPIRA
  • [8] GRIMES D, 1991, LOS ANGELES TIM 0617
  • [9] KAREN G, 1990, RU 486 NEW ISSUES AM
  • [10] EARLY TERMINATION OF PREGNANCY WITH MIFEPRISTONE (RU-486) AND THE ORALLY ACTIVE PROSTAGLANDIN MISOPROSTOL
    PEYRON, R
    AUBENY, E
    TARGOSZ, V
    SILVESTRE, L
    RENAULT, M
    ELKIK, F
    LECLERC, P
    ULMANN, A
    BAULIEU, EE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (21) : 1509 - 1513